Market Tracker

05/25 5:15pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

18.40
Delayed Data
As of May 25
 +0.04 / +0.22%
Today’s Change
11.41
Today|||52-Week Range
21.48
-9.18%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close18.36
Today’s open18.46
Day’s range18.23 - 18.66
Volume452,693
Average volume (3 months)1,010,914
Market cap$2.9B
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-290.40%
Earnings growth (next 5 years)+22.89%
Revenue growth (last year)+115.84%
P/E ratio35.4
Price/Sales8.90
Price/Book13.62

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc+0.47+1.64%
BPMCBlueprint Medicines ...-0.91-1.08%
XLRNAcceleron Pharma Inc-0.13-0.36%
XONIntrexon Corp+0.16+1.03%
Data as of 4:02pm ET, 05/25/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$316.6M
Annual profit (last year)$63.0M
Net profit margin19.89%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts